Clinical features of immune-mediated hepatotoxicity induced by immune checkpoint inhibitors in patients with cancers

Purpose The risk factors and clinical characteristics of ICI-induced immune-mediated hepatotoxicity (IMH) are not fully understood. Thus, the present study sought to clarify the clinical features of IMH. Methods All patients treated with ICIs between September 2014 and April 2019 at our institution...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cancer research and clinical oncology 2021-06, Vol.147 (6), p.1747-1756
Hauptverfasser:	Yamamoto, Atsushi, Yano, Yoshihiko, Ueda, Yoshihide, Yasutomi, Eiichiro, Hatazawa, Yuri, Hayashi, Hiroki, Yoshida, Ryutaro, Asaji, Naoki, Shiomi, Yuuki, Tobimatsu, Kazutoshi, Sakai, Arata, Kodama, Yuzo
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer Research Hematology Hepatotoxicity Immune checkpoint Internal Medicine Medical records Medicine Medicine & Public Health Melanoma Oncology Original Article – Clinical Oncology Patients Risk factors Skin cancer Steroid hormones Therapeutic applications Transaminase
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!